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Treatment of human promyelocytic (HL60) ceils with retinoic acid for at least 48 h causes differentiatjon 
to more mature myeloid forms. Prior to commitment of cells to the myetoid pathway there is a marked 
increase in cytosolic calcium-activated, phospholipid-dependent protein kinase activity. This increase does 
not result from an intracellular redistribution of the enzyme. Concomitant with the increased enzyme activ- 
ity there is enhanced phospholipid-dependent phosphorylation of proteins of 29, 49, 52, 58, 68, 69, 120, 
170,200 and 245 kDa. 
protein kinase Lel~kemia 
1. INTRODUCTION 
The human promyelocyte cell line HL60 can be 
induced to differentiate terminally into cells with 
many of the characteristics of mature granulocytes 
or macrophages by addition of the appropriate 
chemicals. RA induces differentiation along the 
myeloid pathway [I] while the phorbol ester TPA 
leads to transformation into macrophages [Z]. It 
has been shown that each HL60 cell is bipotent and 
can differentiate along either pathway [3] and that 
induction by TPA is dominant. The biochemical 
mechanisms by which RA produces differentiation 
remain unclear but it causes a marked activation of 
cyclic AMP-dependent protein kinase both in 
HL60 [4] and F9 embryonal carcinoma cells IS]. In 
both cases, there is synergistic induction of dif- 
ferentiation by RA and agents which elevate in- 
tracellular cyclic AMP levels [6-81 suggesting that 
the primary action of RA is upon some other pro- 
Abbreviations: Ca’+, PL protein kinase, calcium- 
activated phospholipid-dependent protein kinase; TPA, 
12-O-tetradecanoyl phorbol- 13-acetate; RA, retinoic 
acid; NSE, non-specific esterase 
~i~rerentiution Retinoic acid 
cess. Recently, it has been shown that RA treat- 
ment also elevates the activity of a Ca’+,PL pro- 
tein kinase in IF9 cells I93 and that this enzyme is 
also present in HL60 [lo]. The activity of a kinase 
phosphorylating protamine in a calcium- 
independent manner is elevated in RA-induced 
HL60 [I l] and this enzyme may be identical to 
Ca2’,PL protein kinase fl2]. We have therefore 
studied the effects of RA upon the activity of 
Ca’+,PL protein kinase in HL60 cells and upon the 
in vitro phosphorylation of cytosolic proteins by 
this enzyme. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
HL60 cells were subcultured at an initial density 
1 x IO5 cells/ml in RPM1 1640 suppIemented with 
10% fetal bovine serum (Gibco, Grand Island, 
NY) and incubated for 48 h at 37°C in an at- 
mosphere of 5% CO2 and 100% humidity. In- 
ducers were then added (RA, 1 ,uM; TPA, 64 nM) 
and the cells further incubated. Differentiation 
was assessed by measuring the ability of cells to 
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reduce nitroblue tetrazolium and assaying for cy- 
naphthol AS-D acetate (non-specific) esterase 
(NSE) activity [3]. 
2.2. Enzyme assay 
The cells were harvested by centrifugation, 
washed twice and the cell pellet resuspended in 
2 mM Mops, pH 7.5, 0.5 mM EDTA, 0.5 mM 
EGTA, 1 mM DTT, lOO~g/ml leupeptin. After 
disruption with a Polytron homogenizer the cell 
homogenate was centrifuged for 5 x lo6 g ’ min 
and the supernatant fraction taken for assay. 
Ca’+,PL protein kinase activity was determined in 
a reaction mixture containing 40 mM Mops, pH 
7.5, 5 mM MgS04, 2~~g/ml histone ft, 0.5 mM 
CaCl2, 0.02 mM [y-32P]ATP (925 dpm/pmol) and 
l-10 pg enzyme protein in a final volume of 
120 ~1. Phospholipid-dependent activity was deter- 
mined by adding phosphatidylserine to a final con- 
centration of 25 pug/ml. Protamine kinase activity 
was assayed as described [lo]. After incubation for 
5 min at 30°C duplicate .50-~1 aliquots were quan- 
titated by the disc method of Witt and Roskoski 
[ 131. All assays were in duplicate. One unit of en- 
zyme activity is defined as the transfer of 1 nmol 
32P per min. DEAE-cellulose column chromatog- 
raphy was carried out as in [4]. Protein was deter- 
mined by the method of Bradford [ 141. 
2.3. Protein phosphorylation 
The phosphorylation of cytosolic proteins by en- 
dogenous Ca”,PL protein kinase was performed 
in a reaction mixture consisting of 40 mM Mops, 
pH 7.5,5 mM MgS04, 1 mM DTT, 1 mM EDTA, 
1 mM EGTA, 20pM [y-32P]ATP (9250 dpm/ 
pmol) and 1OOpg protein in a total volume of 
100~1. Assays were carried out in the presence of 
100 PM free Ca2+ and in the presence and absence 
of 25 &g/ml phosphatidylserine. Reactions were 
started by adding enzyme and incubation was for 
2 min at 30°C. The phosphorylation was ter- 
minated by adding SDS and SDS-gradient gel elec- 
trophoresis performed according to Laemmli [ 151 
on 617% gels of acrylamide: bisacrylamide 
(3O:O.g). The gels were dried and autoradio- 
graphed using Min-R film and the autoradiograms 
analyzed using a Zeineh Sl-504 SL laser den- 
sitometer. The density of silver grains was directly 
proportional to the 32P radioactivity present in the 
phosphoproteins. 
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3. RESULTS AND DISCUSSION 
The addition of 1 PM RA to HL60 cells causes 
more than 90% of the cells to differentiate along 
the myeloid pathway and to express NBT reduc- 
tion as a marker of more mature myeloid forms 
[I ,4]. Two aspects of this process are significant. 
First, maximum differentiation is observed (at 5 
days) when cells are exposed to RA for 48 h but ex- 
posure for only 24 h gives a greatly reduced 
response (table 1). Second, the cells exposed to RA 
for 48 h are not irrevocably committed to differen- 
tiation along the myeloid lineage as the addition of 
TPA at that time will cause these cells to acquire 
the adherent properties and NSE activity 
characteristic of monocyte-macrophage differen- 
tiation. Therefore, any biochemical process ex- 
pressed in the first 48 h after RA addition could be 
a causative influence in differentiation along the 
myeloid pathway. 
The effect of inducers upon cytosolic Ca’+,PL 
protein kinase activity is shown in table 2. After 
24 h in the presence of RA there is a small but 
significant elevation of enzyme activity and by 
48 h activity has more than doubled. Activity con- 
tinues to rise up to 96 h by which time it is elevated 
4.5-foid. It has previously been shown that the ad- 
dition of TPA leads to a rapid association of the 
Ca’+,PL protein kinase to membrane fractions of 
HL60 [ 161 and other cell types [ 171. We have con- 
firmed these observations in HL60. However, 
Table 1 
Differentiation of HL,60 cells by retinoic acid and TPA 
Treatment Time NBT-positive NSE-positive 
(h) cells cells 
(Q) (070) 
None 5 3 
Retinoic acid 0.5 8 N.D. 
24 24 N.D. 
48 91 5 
120 95 6 
TPA 48 24 83 
Retinoic acid + 
TPA 48 + 48 26 81 
RA was present for the time indicated and NBT and 
NSE positive cells were analyzed 120 h after the initial 
addition of RA or 48 h after the addition of TPA 
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Table 2 
Time course of the effect of retinoic acid upon cytosolic Ca’+ activated, 
PL-dependent protein kinase activity 
Time after Time after Ca’+,PL protein Protamine kinase 
adding RA adding TPA kinase activity activity 
(h) (h) (U/mg protein) 
0 0.208 2.81 
24 0.281 4.08 
48 0.486 5.88 
96 0.929 10.93 
48 0.25a 0.267 3.83 
48 la 0.203 2.71 
48 2a 0.202 2.93 
48 48a 0.056 1.23 
a Added after 48 h RA pretreatment 
when cells are induced for 48 h with RA, and then 
TPA is added, there is now only a rapid loss of 
part of the cytosolic Ca”,PL protein kinase sug- 
gesting that RA causes the appearance in the 
cytosol of an altered form of the enzyme which 
TPA will not cause to associate rapidly with par- 
ticulate fractions. 
As an initial approach to the study of this 
possibility Ca2+,PL protein kinase activities from 
control, RA-induced and RA-induced TPA- 
treated cells were analyzed by DEAE-cellulose 
chromatography (fig.1). The enzyme elutes as a 
single major peak at approx. 0.15 M NaCl in be- 
tween the peaks of type I and II cyclic AMP depen- 
dent protein kinase. This elution profile is identical 
to that reported for protamine kinase activity [ 111, 
strongly suggesting that the activities measured by 
assaying protamine phosphorylation in the absence 
of Ca2+ and PL and histone fi phosphorylation in 
the presence of Ca*+ and PL are the same enzyme; 
a conclusion supported by the observation that the 
homogeneous enzyme from bovine heart has both 
activities [12] and the close correlation between the 
levels of Ca2+,PL protein kinase and protamine 
kinase activities in table 2. Although there is a 
single major peak of activity, this peak is not sym- 
metrical and there is apparently another minor 
form, less PL-sensitive which elutes at 0.21 M 
NaCl. When the profiles of enzyme activity from 
the 3 conditions are compared there is no evidence 
of significant differences between them. Further- 
June 1985 
Fig. 1. ~EAE-cellulose chromatography of Ca’+,PL 
protein kinase. Cytosolic extracts of control (upper), 
48 h RA-treated (middle) and 48 h RA-induced and 1 h 
TPA-treated (lower) HL60 cells were fractionated upon 
DEAE-cellulose and the fractions assayed: (A) with 
Ca2+, (m) with PL, ( q ) with Ca2+ and PL. (- - %) Protein 
profile. 
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(-) PS (+I PS 
R&(h)0 8 24 48 12 96 0 8 24 48 72 96 
M, x 10-3 
31- 
-29 
Fig.2. Effect of retinoic acid-induced differentiation 
upon phosphatidylserine-dependent in vitro cytosolic 
protein phosphorylation. 
more, analysis of the properties of the enzymes 
from the peak fractions of each column does not 
reveal any significant differences in the pH profile 
or Ca’+ or PL concentration dependence (not 
shown). Thus although TPA inhibition suggests 
RA induces an altered molecular form of the en- 
zyme we have not found any simple differences 
between the enzyme in control and RA-treated 
cells. Since Ca’+,PL protein kinase activity is 
found both in the cytosol and associated with 
membranes, one possibility is that RA could cause 
release of enzymes from the particulate fraction 
and TPA would cause reassociation. To assay 
Ca2+,PL protein kinase activity in particulate frac- 
tions it is necessary to detergent-solubilize the en- 
zyme from the membranes and then reduce the 
detergent concentration to levels which do not ac- 
tivate the kinase. We have not so far succeeded in 
obtaining preparations which are reproducibly ac- 
tivated by PL. However, it is possible to extract 
reproducibly protamine kinase activity and we 
have previously shown that the particulate activity 
of this enzyme is raised more than 2-fold by RA 
treatment indicating that RA does not cause 
release of particulate enzyme [ 111. 
Kuo and co-workers [lo] have reported the Ca2+ 
and PL-dependent in vitro phosphorylation of 
proteins of 34, 38, 45 and 100 kDa in the cytosol 
of uninduced HL60 cells. We reproducibly find 
proteins of 29,49, 52, 58,68, 69, 120, 170,200 and 
245 kDa whose phosphorylation is either greatly 
enhanced or totally dependent upon the presence 
of phosphatidylserine and whose phosphorylation 
is increased upon the treatment of HL60 cells with 
RA (fig.2). We have quantitated the autoradio- 
grams using a laser densitometer. Within 24 h 
there is a significant (>75%) increase in the incor- 
poration of 32P into proteins of 49, 52 and 58 kDa; 
by 48 h similar increases in 29, 68, 69, 170 and 
245 kDa proteins have occurred and by 72 h the 
120 and 200 kDa phosphorylations are enhanced. 
These changes are not the result of overall in- 
creases in protein phosphorylation as the two ma- 
jor phosphorylated proteins of control cells of 98 
and 125 kDa begin to decrease by 24 h and are 
reduced by more than 80% by 48 h. Furthermore 
the phosphorylation of the 98 kDa protein is 
dependent upon the presence of calcium (not 
shown). The addition of 10pM RA to the phos- 
phorylation assay did not enhance the phosphor- 
ylation of any of the bands indicating that the ef- 
fect of RA is indirect. 
These results indicate that there are major in- 
creases in the Ca2+ and PL-dependent 
phosphorylation of cytosolic proteins and an in- 
crease in Ca’+,PL protein kinase in HL60 cells 
treated with RA prior to the commitment of the 
cells to the myeloid pathway. We do not know 
whether the enhanced protein phosphorylation is 
due to the appearance of a modified form of the 
Ca2+,PL protein kinase or to the synthesis of new 
protein substrates. Enhanced protein synthesis of 
molecules of 32, 34 and 60 kDa has been reported 
[ 181. Further studies will determine the significance 
of these events to the myeloid differentiation of 
HL60. 
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